Comparative analysis of hematological changes in patients with rheumatoid arthritis treated with different Janus kinase inhibitors: a real-world study
Although all three JAK inhibitors reduced ANC, baricitinib was associated with a substantial increase in platelet counts. These findings highlight the differences in adverse effect profiles among JAK inhibitors, emphasizing the importance of tailored monitoring in RA management.
Authors
- Yong‐Gil Kim (ORCID: https://orcid.org/0000-0002-8029-7355)
- Seokchan Hong (ORCID: https://orcid.org/0000-0001-8722-3124)
- Bin Yoo (ORCID: https://orcid.org/0000-0002-1836-5273)
- Chang‐Keun Lee (ORCID: https://orcid.org/0000-0003-3653-7515)
- Ji Seon Oh (ORCID: https://orcid.org/0000-0002-0205-6492)
- Soo Min Ahn (ORCID: https://orcid.org/0000-0002-9213-9768)
Institutions
- Ulsan College (KR)
- Asan Medical Center (KR)
- University of Ulsan (KR)
Publication Details
- Journal
- Journal of Rheumatic Diseases
- Published
- 2025-09-26
- DOI
- https://doi.org/10.4078/jrd.2025.0081
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00